Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men-Reference-Cited by-同舟云学术

Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men

Published:2001-12 Issue:6 Volume:13 Page:317-321
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Heaton JPW,Lording D,Liu S-N,Litonjua AD,Guangwei L,Kim SC,Kim JJ,Zhi-zhou S,Israr D,Niazi D,Rajatanavin R,Suyono S,Benard F,Casey R,Brock G,Belanger A

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/3900760.pdf

Reference15 articles.

1. McCulloch DK et al.. The prevalence of diabetic impotence. Diabetologia 1980 18, 279–283.

2. Dunsmuir WD, Holmes SAV. . The aetiology and management of erectile, ejaculatory and fertility problems in men with diabetes mellitus. Diabetic Medicine 1996 13, 700–708.

3. Linet OI, Ogrinc FG. . Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New Engl J Med 1996 334, 873–877.

4. The European Alprostadil Study Group. . The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. Br J Urol 1998 82, 538–543.

5. Ravnik-Oblak M et al. Intracavernous injection of prostaglandin E1 in impotent diabetic men. Int J Impot Res 1990 2, 143–150.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic Neuropathy: Clinical Management—Genitourinary Dysfunction in Diabetes;Contemporary Diabetes;2023

2. Urologic Complications in Patients with Diabetes;The Diabetes Textbook;2023

3. The management of erectile dysfunction in men with diabetes mellitus unresponsive to phosphodiesterase type 5 inhibitors;Andrology;2022-08-17

4. The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial;Frontiers in Endocrinology;2022-06-23

5. Managing erectile dysfunction in people with diabetes;Independent Nurse;2022-03-02